Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,000 | 214 | 95.2% |
| Education | $182.06 | 3 | 3.5% |
| Unspecified | $69.78 | 1 | 1.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,948 | 142 | $0 (2024) |
| Janssen Biotech, Inc. | $415.46 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $392.55 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $162.76 | 6 | $0 (2020) |
| GENZYME CORPORATION | $144.22 | 2 | $0 (2023) |
| Aries Pharmaceuticals, Inc. | $123.50 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $123.26 | 1 | $0 (2018) |
| Covidien LP | $123.14 | 1 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $121.34 | 1 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $120.68 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $439.85 | 30 | ABBVIE INC. ($314.64) |
| 2023 | $779.43 | 46 | ABBVIE INC. ($443.53) |
| 2022 | $503.07 | 22 | ABBVIE INC. ($323.16) |
| 2021 | $357.47 | 12 | AbbVie Inc. ($236.65) |
| 2020 | $386.86 | 18 | Covidien LP ($123.14) |
| 2019 | $822.72 | 24 | AbbVie, Inc. ($331.92) |
| 2018 | $1,058 | 29 | AbbVie, Inc. ($376.35) |
| 2017 | $904.27 | 37 | AbbVie, Inc. ($807.46) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 262 | 270 | $179,584 | $28,774 |
| 2022 | 10 | 366 | 387 | $235,432 | $44,149 |
| 2021 | 10 | 397 | 429 | $230,059 | $44,880 |
| 2020 | 12 | 343 | 398 | $241,366 | $40,327 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 59 | 60 | $77,460 | $11,635 | 15.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 42 | $18,816 | $5,225 | 27.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 59 | $43,365 | $4,540 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 46 | $11,050 | $3,280 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 23 | $5,405 | $1,454 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 24 | $3,840 | $1,376 | 35.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $19,648 | $1,265 | 6.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 74 | 74 | $83,472 | $14,713 | 17.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 43 | $19,264 | $6,489 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 75 | 81 | $19,035 | $5,713 | 30.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 67 | 69 | $50,715 | $5,106 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $7,942 | $2,455 | 30.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $10,790 | $2,444 | 22.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 42 | $7,011 | $2,320 | 33.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $9,130 | $2,067 | 22.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $21,000 | $1,903 | 9.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,073 | $939.85 | 13.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 60 | 61 | $68,808 | $11,989 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 103 | 118 | $27,730 | $9,678 | 34.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 37 | $19,852 | $5,917 | 29.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 64 | 68 | $49,980 | $5,786 | 11.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 23 | 23 | $8,303 | $2,742 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 38 | $8,990 | $2,182 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 27 | $13,360 | $2,111 | 15.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 17 | 18 | $18,000 | $1,603 | 8.9% |
About Dr. Christopher Hodnette, MD
Dr. Christopher Hodnette, MD is a Emergency Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992140065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Hodnette, MD has received a total of $5,252 in payments from pharmaceutical and medical device companies, with $439.85 received in 2024. These payments were reported across 218 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,000).
As a Medicare-enrolled provider, Hodnette has provided services to 1,368 Medicare beneficiaries, totaling 1,484 services with total Medicare billing of $158,130. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Baton Rouge, LA
- Active Since 05/02/2013
- Last Updated 03/23/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1992140065
Products in Payments
- Humira (Biological) $969.87
- RINVOQ (Biological) $668.78
- STELARA (Biological) $381.78
- HUMIRA (Biological) $278.31
- Entyvio (Biological) $219.79
- SKYRIZI (Biological) $201.66
- Mavyret (Drug) $179.81
- REMICADE (Biological) $156.94
- DUPIXENT (Biological) $144.22
- CREON (Drug) $141.34
- ELEVIEW (Device) $123.50
- EndoFlip (Device) $123.14
- TERLIVAZ (Drug) $121.34
- Linzess (Drug) $120.68
- XIFAXAN (Drug) $112.21
- XELJANZ (Drug) $99.94
- LINX Reflux Management System (Device) $92.72
- LINZESS (Drug) $91.28
- TRULANCE (Drug) $90.71
- Viekira (Drug) $88.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Baton Rouge
Dr. Wame Waggenspack, M.d, M.D
Emergency Medicine — Payments: $69,580
Dr. John Uhl, M.d, M.D
Emergency Medicine — Payments: $8,994
Dr. Todd Howell, M.d, M.D
Emergency Medicine — Payments: $3,889
Dr. Owen Stell, M.d, M.D
Emergency Medicine — Payments: $2,307
Dr. Lambert Laperouse, M.d, M.D
Emergency Medicine — Payments: $1,750
Cheryl Hickey, M.d, M.D
Emergency Medicine — Payments: $1,196